Physician

Ibrahim Atsejuwawe Usman-Oyowe, M.D

According to 2025 Medicare claims, Ibrahim Usman-Oyowe, M.D (NPI: 1255695136) practices physical medicine and rehabilitation in the Valdosta, GA market, with the plurality of this provider's patient population coming from Lowndes, GA. This provider's primary affiliated billing organization is VALDOSTA ORTHOPEDIC ASSOCIATES PC (NPI: 1053457457; TIN: 581234117) and primary practice location at 31602-6418.

Usman-Oyowe's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 618 traditional Medicare patients, billed 10,914 HCPCS/CPT codes, and received $321,361 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 11,776 prescription claims across 930 beneficiaries totaling $645,490 in drug costs, led by Relistor (Methylnaltrexone Bromide). DME data shows 252 claims. Open Payments data shows 27 records totaling $765. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $10,914 to $321,361. Similarly, Part D prescription costs have moved sharply higher in recent years, from $4,638 to $645,490. In contrast, DME billing represents a smaller volume and moved up and down with repeated peaks and valleys, starting at $6,958 and ending at $29,259.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	93	167	$10,914
2017	176	624	$43,947
2018	327	2,656	$188,025
2019	461	3,534	$234,600
2020	432	3,622	$245,861
2021	473	3,462	$237,313
2022	492	3,876	$239,959
2023	569	4,863	$294,255
2024	618	10,914	$321,361

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	N/R	N/R
2016	44	95	$4,638
2017	105	226	$8,231
2018	132	424	$21,322
2019	224	1,340	$71,874
2020	307	3,389	$142,042
2021	418	4,521	$218,775
2022	552	5,835	$284,115
2023	730	8,335	$510,189
2024	930	11,776	$645,490

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	36	100	$4,011
2020	107	305	$15,172
2021	95	459	$19,054
2022	36	344	$13,353
2023	26	208	$20,736
2024	16	252	$21,510

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	343	849	$89
95886	Needle measurement of electrical activity in arm or leg muscles, complete study	186	369	$67
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	280	779	$64
80305	Testing for presence of drug, read by direct observation	284	578	$12
96127	Assessment of emotional or behavioral problems	140	140	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Relistor	Methylnaltrexone Bromide	72	2,120	$164,327
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	2,077	60,980	$67,462
Xtampza Er	Oxycodone Myristate	92	2,729	$65,708
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	1,466	43,403	$54,206
Linzess	Linaclotide	87	2,640	$46,984

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
E0466	Home ventilator, any type, used with non-invasive interface, (e.g., mask, chest shell)	Y	N/R	12	$12,065
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	N/R	37	$2,732
E0260	Hospital bed, semi-electric (head and foot adjustment), with any type side rails, with mattress	Y	N/R	43	$2,306
K0003	Lightweight wheelchair	Y	N/R	37	$1,363
K0001	Standard wheelchair	Y	N/R	41	$1,109

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	27	$765	Nevro Corp.
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ibrahim Atsejuwawe Usman-Oyowe, M.D?

Tedicare shows public-source Medicare data for Ibrahim Atsejuwawe Usman-Oyowe, M.D (NPI 1255695136), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ibrahim Atsejuwawe Usman-Oyowe, M.D have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Ibrahim Atsejuwawe Usman-Oyowe, M.D?

Ibrahim Atsejuwawe Usman-Oyowe, M.D is linked to VALDOSTA ORTHOPEDIC ASSOCIATES PC (billing NPI 1053457457) in the available physician profile data.

Does Ibrahim Atsejuwawe Usman-Oyowe, M.D have Open Payments data?

Ibrahim Atsejuwawe Usman-Oyowe, M.D has 27 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.